Back to search

Article

TET2 Deficiency Increases the Competitive Advantage of Hematopoietic Stem Cells through Upregulation of Thrombopoietin Receptor Signaling

2024-03-25

Abstract excerpt

<title>Abstract</title> <p>Ten-Eleven Translocation-2 (<italic>TET2</italic>) mutations drive the expansion of mutant hematopoietic stem cells (HSCs) in clonal hematopoiesis (CH). However, the precise mechanisms by which <italic>TET2</italic> mutations confer a competitive advantage to HSCs remain unclear. Here, through an epigenetic drug screen, we discovered that inhibition of disruptor of telomeric silencing 1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1eefe72-2195-5001-9d63-e1999c64adde
DOI
10.21203/rs.3.rs-4151500/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TET2 Deficiency Increases the Competitive Advantage of Hematopoietic Stem Cells through Upregulation of Thrombopoietin Receptor SignalingDOI 10.21203/rs.3.rs-4151500/v1
Select a neighboring publication to make it the new centre.